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Selection of outcome measures for a trial of not routinely measuring gastric residual 
volume in neonatal care: a mixed methods consensus process 
 
Abstract (250 words) 
 
Background: Routine measurement of gastric residual volume to guide feeding is 
widespread in neonatal units but not supported by high-quality evidence. Outcome selection 
is critical to trial design. 
Objective: To determine optimal outcome measures for a trial of not routinely measuring 
gastric residual volume in neonatal care. 
Design: A focused literature review; parent interviews; modified two-round Delphi survey 
and stakeholder consensus meeting. 
Participants: Sixty-one neonatal healthcare professionals participated in an eDelphi survey; 
17 parents were interviewed. 19 parents and neonatal healthcare professionals took part in 
the consensus meeting. 
Results: Literature review generated 14 outcomes and parent interviews contributed eight 
additional outcomes; these 22 outcomes were then ranked by 74 healthcare professionals in 
the first Delphi round where four further outcomes were proposed; 26 outcomes were ranked 
in the second round by 61 healthcare professionals. Five outcomes were categorised as 
‘consensus in’, no outcomes were voted ‘consensus out’. ‘No consensus’ outcomes were 
discussed and voted on in a face-to-face meeting by 19 participants, where four were voted 
‘consensus in’. The final nine consensus outcomes were: mortality, necrotising enterocolitis, 
time to full enteral feeds, duration of parenteral nutrition, time feeds stopped per 24 hours, 
healthcare associated infection; catheter associated bloodstream infection, change in weight 
between birth and neonatal discharge and pneumonia due to milk aspiration. 
Conclusions and relevance: We have identified outcomes for a trial of no routine 
measurement of gastric residual volume to guide feeding in neonatal care. This outcome set 





Heterogeneity in outcome selection limits evidence synthesis and is a problem in neonatal 
care1 where meta-analyses rarely provide conclusive recommendations2. Neonatal trial 
outcomes are often not meaningful to parents and patients3,4; selection of clinically relevant 
outcomes that are important to parents and patients is key to improving uptake of research 
into practice5. A solution is the development and application of core outcome sets, important 
outcomes identified by key stakeholders using robust consensus methods6. The Core 
Outcomes In Neonatology (COIN) set has been identified7 and should be the minimum8 
standard for neonatal effectiveness trials, however research questions often measure 
additional specific outcomes; selection of these should also involve key stakeholders and 
robust methodology. 
 
This study is part of a larger National Institute for Health Research (NIHR) funded mixed 
methods feasibility study (GASTRIC) to determine whether it was possible to conduct a 
future trial comparing no routine gastric residual volume measurement with routine gastric 




A four stage mixed method study followed established methodology for identification of core 
outcomes for trials6, March 2018 - April 2019:  
1.  A focused literature review of outcomes reported in clinical trials and observational 
studies of gastric residual volume measurement in critically ill adults, children or neonates: 
Databases were searched (Medline, CINAHL, Proquest) in March 2018 by LNT using the 
search terms: ‘gastric residual’ and ‘gastric aspirate’ in critically ill patients. Outcomes were 
extracted from identified studies.  
 
2. Parent interviews: Qualitative researchers (LR and ED) recruited English-speaking 
parents of children that received neonatal care in the last three years via social media, 
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national networks, word of mouth and a newspaper advertisement. A participant information 
sheet listing potential outcomes identified from the focused literature review was emailed to 
parents to read prior to interview. Based on previous research10 it was anticipated that 10-15 
parents would be recruited to reach data saturation point11. Interviews explored views on the 
proposed GASTRIC trial and which outcomes parents felt would be important. Content 
analysis12 was used to identify outcomes to inform the subsequent Delphi study.   
3. Delphi Study: A modified 2-round Delphi13 e-survey was developed from the literature 
review and the parent interviews (Supplementary File 1) and pilot tested for clarity and face 
validity with ten healthcare professionals and the study team, and input into 
DelphiManager14.  Nurses, doctors, pediatric surgeons and dietitians working in neonatal 
units were invited to take part via email through professional networks. The target number of 
respondents was 100 to ensure representation from key stakeholder groups with 
understanding of relevant issues, and consistent with previous core outcome sets6; 
automated reminders were sent weekly.  
Round 1 summarised previous trial designs and outcomes used, and listed a set of 
outcomes to score using a 9-point Likert scale as recommended by the Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) working group15, 1–
3 signifying ‘not important’, 4–6 ‘important but not critical’ and 7–9 ‘critical’. Participants were 
able to comment and asked to suggest additional relevant outcomes. Outcomes were listed 
alphabetically to avoid bias due to the order displayed. After Round 1 the study management 
group reviewed additional suggested outcomes and added distinct outcomes to the second 
round. In Round 2, participants were presented with descriptive statistics and histograms of 
Round 1 scores for each outcome by stake-holder group, asked to re-score these outcomes, 
to score additional outcomes suggested in Round 1, and to specify a single primary 
outcome. 
The Round 2 scores were used to formulate consensus statistics for each outcome overall 
and by stakeholder group, using pre-defined cut-offs for ‘Consensus In’ (≥70% participants 
scoring 7 to 9 AND <15% participants scoring 1 to 3 in each stakeholder group), ‘Consensus 
Out’ (≥70% participants scoring 1 to 3 AND <15% participants scoring 7 to 9 in each 
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stakeholder group), ‘No consensus’ (anything else). Consensus thresholds were defined a 
priori consistent with published guidance and previous studies6. 
4. Face-to-face consensus meeting: Parents, clinical trial methodologists and neonatal 
healthcare professionals were invited to review the results of the mixed-methods study, vote 
on outcomes that did not reach consensus in the Delphi survey and discuss future trial 
feasibility and design. An independent facilitator led the meeting. Voting results were 
summarised using the same methodology as described for the Delphi.  
 




The focused literature review identified six studies, one in children16, three in adults17-19 and 
two in preterm neonates20,21. Reported outcomes were summarised (Table 1). Incidence of 
ventilator associated pneumonia was not reported in the neonatal studies and therefore not 
included in the neonatal Delphi, gastrointestinal morbidity was separated into vomiting and 
diarrhea, generating 14 items from the literature review. Figure 1 shows the generation of 
outcomes across the study. 
Parent-important outcomes 
Seventeen parents of 19 children (two mothers had twins) who received neonatal care in 21 
hospitals were interviewed. Interviews took place on average 11 months (range 0.8 - 37 
months) after neonatal admission. Reasons for neonatal care were preterm birth (n=18) and 
meconium aspiration syndrome (n=1). Parents split ‘long-term neurodevelopment’ into long-
term hearing loss, problems with vision, problems with cognition and motor problems (such 
as cerebral palsy), and proposed four further outcomes: time from birth to nasogastric tube 
removal, total length of time on any respiratory support, brain injury on imaging, and 
healthcare associated infections. 
Delphi Study  
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In November 2018, healthcare professionals at all 184 neonatal units in England, Scotland 
and Wales were contacted via email; 76 individuals registered for the survey, 74 went on to 
score 22 outcomes in Round 1, and of these, 61/74 (80%) went on to complete Round 2. 
Four additional outcomes were suggested by respondents in Round 1: change in head 
circumference, incidence of pneumonia due to aspiration of feeds; incidence of catheter 
associated bloodstream infection, time to oral feeding; 26 outcomes were included in Round 
2. 76% (46/61) of respondents changed their score for at least three outcomes from Round 1 
to Round 2. There was no evidence of attrition bias between rounds; the 13 healthcare 
professionals that only took part in Round 1 had similar views to those who took part in both 
rounds (supplemental figures). After Round 2 ‘consensus in’ was achieved for five outcomes: 
mortality; incidence of necrotising enterocolitis; time to full enteral feeds; duration of 
parenteral nutrition; time feeds stopped per 24-hour period. No outcomes were voted 
‘consensus out’. Outcomes scored in Round 2 are shown in Table 2 with the outcome 
source and consensus status.  
Respondents were asked their choice of primary outcome for a future trial: 48/61 (79%) 
respondents suggested at least one; the most common were incidence of necrotising 
enterocolitis (24/61; 39%) and time to full enteral feeds (18/61; 30%). 
Consensus meeting 
Nineteen participants (1 charity representative; 1 clinical trialist/methodologist; 2 neonatal 
dietitians; 5 neonatal doctors; 7 neonatal nurses; 1 paediatric surgeon; 2 parents) attended 
the consensus meeting on 1st April 2019, representing 14/184 (8%) of UK neonatal units, 
three universities and the charity Bliss. Some had participated in the Delphi study. At this 
meeting there was discussion and voting on the 21 outcomes that did not reach consensus 
in the Delphi. Using the same scoring criteria as the Delphi survey, four items were voted 
‘consensus in’, four were voted ‘consensus out’ and 13 failed to reach any consensus (Table 






This study reports a set of outcomes identified as important by healthcare professionals and 
parents for a trial comparing no routine measurement of gastric residual volumes in neonatal 
care to routine measurement. This study-specific outcome set was developed following a 
robust process with involvement of key stakeholder groups. This is one of the few studies to 
apply such methods to outcome selection in neonatal or paediatric care. Poor outcome 
selection is increasingly recognised as a source of research waste1,22. The use of study-
specific outcome sets in conjunction with relevant Core Outcome Sets, such as COIN7, will 
ensure trials support evidence synthesis, are relevant to parents and inform clinical practice. 
 
Gastric residual volume is a measurement of the volume of the entire stomach contents from 
aspirating with a syringe, and is distinct from the aspiration of a small volume of gastric fluid 
for pH testing to confirm gastric tube position. Routine measurement of gastric residual 
volume commonly informs feeding decisions in neonatal units in the UK23 and internationally. 
The rationale underpinning this is to assess ‘feed tolerance’ and to predict, and potentially 
prevent, necrotising enterocolitis by withholding enteral feeds24,25. However, there is minimal 
evidence to support routine measurement of gastric residual volumes in neonatal care. A 
recent single-centre trial found that avoiding routine measurement of gastric residual 
volumes may be beneficial, leading to higher weight gain and shorter length of stay26, 
however trials to date have not had power to evaluate the relationship between gastric 
residual measurement and necrotising enterocolitis26,27. Despite potential harms such as 
mucosal injury, and evidence that gastric residual volume is an inaccurate measure of 
gastric contents28, routine assessment of gastric residual volumes is engrained in neonatal 
care29. This study was commissioned by the United Kingdom NIHR as part of a wider piece 
of work to evaluate the feasibility of a multi-centre trial examining no routine measurement of 
gastric residual volumes. This study identifies a set of outcomes for such a trial which 
comprise uncommon but severe events (mortality, necrotising enterocolitis, pneumonia 
secondary to milk aspiration and infection) and nutritional outcomes (time to full enteral 
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feeds, days of parenteral nutrition, number of times that feeds are stopped, change in 
weight). While there is some overlap with core outcomes identified for neonatal research 
generally7, this study specific outcome set more closely targets nutritional outcomes – 
highlighting the importance of using general core outcome sets in conjunction with trial 
specific consensus processes that involve parents and patients.  
 
Previous neonatal trials have targeted nutritional outcomes (time to achieve full enteral 
feeds) as the primary outcome. Although these studies have reported necrotising 
enterocolitis, event rates have been low. Healthcare professionals are highly concerned 
about adverse events30 and may fear these more than they value improved outcomes. This 
study confirms that the adverse outcome necrotising enterocolitis is key across all 
stakeholder groups for this clinical question. The incidence of necrotising enterocolitis is low 
among all but the most preterm infants31 and therefore any trial seeking to demonstrate 
superiority or non-inferiority for such an outcome will require high numbers and multiple 
sites. Previous trials have not had sufficient size to detect differences in necrotising 
enterocolitis, which may in part explain why routine measurement of gastric residuals 
remains entrenched in neonatal practice single-centre trials that indicate it is detrimental.   
 
Strengths include a pre-registered approach that identified trial outcomes for the Delphi 
survey and consensus meeting from both previous research and parents with experience of 
neonatal care. Limitations include the incomplete participation of UK neonatal units in the 
Delphi survey, although the response rate of 40% is in keeping with other surveys. The 
consensus process was deliberately limited to UK neonatal professionals and parents to 
determine the feasibility of a UK trial, which limits generalisability to other healthcare 
settings. Some identified outcomes overlap or are not well defined in neonates, and will 
require refinement prior to any future trial. We had only limited participation in the Delphi 
from neonatal dieticians, however this group was well represented in the final consensus 
meeting. We did not include parents in the Delphi survey as asking for parental views on 
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outcomes at interview and involving them in the final consensus meeting were felt to be the 
most appropriate ways to gain meaningful input from this group.  
 
Conclusions 
We describe development of an outcome set for a trial comparing no routine gastric residual 
volume measurement with routine measurement to guide feeding in neonatal care. This was 
identified though a consensus approach involving parents and neonatal clinical stakeholder 
groups. The use of such outcomes increases the likelihood that future trial results are both 
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Table 1: Outcomes identified in previous studies of gastric residual volume measurement  
Outcome Patient population 
1. Intensive care unit length of stay All  
2. Hospital length of stay All 
3. Length of invasive ventilation All 
4. Occurrence of ventilator associated pneumonia  Adult and paediatric 
5. Achievement of predicted energy goals using various definitions: 
Proportion of patients achieving 100% 
Cumulative calorie deficit over 7 days 
Ratio of prescribed/achieved energy target 
Enteral feeding ‘adequacy’ 
Median daily volume of feed given  
Percentage of predicted energy requirement achieved per day 
Time to achieve full feeds for preterm neonates (120ml/kg and 150ml/kg/day) 
Adult, paediatric and neonatal 
6. Occurrence of necrotising enterocolitis Neonatal and paediatric  
7. Incidence of gastro-intestinal intolerance: vomiting, diarrhea, abdominal 
distention, feed intolerance, gastro-esophageal reflux  
Adult and paediatric 
8. Nursing time spent measuring gastric residual volumes Adult 
9. Change in weight from admission to discharge Neonatal and paediatric 
10. Change in length from admission to discharge Neonatal 
11. Days of parenteral nutrition  Neonatal 
12. Days with a central venous catheter in place to deliver parenteral nutrition Neonatal  
13. Time feeds stopped per 24-hour period Adult  




Table 2: Percentage of participants that scored 7, 8 or 9 for each outcome scored in 




Doctors Nurses Dietitians All 
Consen-
sus 
status Outcome (n=40) (n=18) (n=3) (n=61) 
Mortality LR *100% *100% *100% **100% In 
Incidence of necrotising enterocolitis LR *100% *94.4% *100% **98.4% In 
Time from start of enteral feeding to 
achieve full (150ml/kg/day) enteral 
feeds 
LR *92.5% *88.9% *100% **91.8% In 
Healthcare associated infections Parents *87.5% *88.9% 66.7% *86.9% None 
Days on parenteral nutrition LR *77.5% *94.4% *100% **83.6% In 
Incidence of catheter-associated 
blood stream infection 
DR1 
*85% *70.6% 66.7% *80% 
None 
Time feed stopped per 24 hour period LR *70% *83.3% *100% **75.4% In 
Change in weight (growth) between 
birth and neonatal unit discharge 
LR 
*75% *77.8% 66.7% *75.4% 
None 
Days of central venous line access LR *75% *72.2% 66.7% *73.8% None 
Length of stay in hospital LR 45% *72.2% *100% 55.70% None 
Incidence of pneumonia due to milk 
aspiration 
DR1 
37.5% *76.5% 66.7% 50% 
None 
Length of stay neonatal unit LR 35% *72.2% 66.7% 47.5% None 
Long term outcomes: Problems with 
mobility like cerebral palsy  
Parents 
45% 50% 33.3% 45.9% 
None 
Long term outcomes: Problems with 
cognition 
Parents 
35% 38.9% 33.3% 36.1% 
None 
Gastro-intestinal morbidity: Vomiting LR 30% 61.1% *100% 42.6% None 
Change in head circumference 
between birth and neonatal unit 
discharge  
DR1 
42.50% 23.50% *100% 40% 
None 
Change in length (growth) between 
birth and neonatal unit discharge 
LR 
42.50% 27.80% 66.70% 39.30% 
None 
Brain injury on imaging Parents 25% 33.30% 33.30% 27.90% None 
Time to oral feeding DR1 27.50% 23.50% 33.30% 26.70% None 
Length of time invasive ventilation LR 12.5% 50% 66.7% 26.2% None 
Long term outcomes: Hearing loss Parents 15% 27.80% 33.30% 19.70% None 
Long term outcomes: Problems with 
eyesight 
Parents 
15% 27.80% 33.30% 19.70% 
None 
Nursing time spent measuring gastric 
residual volumes  
LR 
5% 27.80% 66.70% 14.80% 
None 
Gastro-intestinal morbidity: Diarrhoea LR 5% 27.80% 33.30% 13.10% None 
Total length of time respiratory 
support (invasive and non-invasive) 
Parents 
2.50% 27.80% 0% 9.80% 
None 
Time to nasogastric tube removal Parents 10% 5.60% 0% 8.20% None 
* ‘Consensus in’ criteria were met: ≥70% scored 7, 8 or 9 and <15% scored 1, 2 or 3;  
** ‘Consensus in’ criteria met in all groups;  
† ‘Consensus out’ criteria were met: ≥70% scored 1, 2 or 3 and <15% scored 7, 8 or 9 [NB: None found];  
†† ‘Consensus out’ criteria met in all groups;  
Source of outcome: LR Literature review; DR1 Delphi Round 1 
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Table 3: No-consensus items voted on at consensus meeting 
Outcome Consensus status 
 
Healthcare associated infections In 
Incidence of catheter-associated blood stream infection In 
Change in weight between birth and neonatal unit discharge In 
Incidence of pneumonia due to milk aspiration In 
Change in head circumference between birth and neonatal unit discharge No Consensus 
Brain injury on imaging No Consensus 
Gastrointestinal morbidity: Vomiting No Consensus 
Length of stay hospital No Consensus 
Length of stay neonatal unit No Consensus 
Length of time receiving invasive ventilation No Consensus 
Long term outcomes: Hearing loss No Consensus 
Long term outcomes: Problems with vision No Consensus 
Long term outcomes: Problems with cognition No Consensus 
Long term outcomes: Brain injury on imaging No Consensus 
Long term outcomes: Motor problems  No Consensus 
Time to oral feeding No Consensus 
Total length of time receiving respiratory support (invasive and non-invasive) No Consensus 
Change in length (growth) between birth and neonatal unit discharge Out 
Gastrointestinal morbidity: Diarrhoea Out 
Nursing time spent measuring gastric residual volume Out 




Table 4: Final nine outcomes gaining consensus for a trial of no gastric residual 







Incidence of necrotising enterocolitis 
Time from start of enteral feeding to achieve full (150ml/kg/day) enteral feeds 
Days on parenteral nutrition 
Time feed stopped per 24 hour period 
Healthcare associated infections 
Incidence of catheter-associated blood stream infection 
Change in weight between birth and neonatal unit discharge 
Incidence of pneumonia due to milk aspiration 
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What is already known on this topic  
1. Routine measurement of gastric residual volume to guide feeding is widespread in 
neonatal units worldwide, but not supported by high-quality evidence 
2. Adequately powered and methodologically robust randomised trials would provide 
evidence about risks and benefits of routine measurement of gastric residual volume 
in neonatal care 
3. Selection of trial outcomes that are relevant to health professionals, parents and 
patients is key to improving the quality and implementation of research 
 
What this study adds  
1. We have identified outcomes for a trial of no routine measurement of gastric residual 
volume to guide feeding in neonatal care. 
2. Consensus outcomes included: mortality, necrotising enterocolitis, time to full enteral 
feeds, duration of parenteral nutrition, time feeds stopped per 24 hours, healthcare 
associated infection 
3. Use of this outcome set in trials of no routine measurement of gastric residual volume 
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